Furthermore, for the first time, ginsenoside Rb1 was verified to function as a protective agent against BV-induced EMT and renal fibrosis in vivo and in vitro through inhibiting ROS generation and Bip/eIF2α/CHOP toxicity pathway and following Ca2+ overload. The gene discussed is EIF2A; the disease is renal fibrosis.